IRWD
Ironwood Pharmaceuticals, Inc. - Class ARecent alerts on IRWD
All signals →
News
Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
6d ago
News
Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug
14d ago
News
Kyverna Therapeutics appoints Greg Martini as CFO
15d ago
News
Ironwood Pharma drops after CFO transition
20d ago
News
Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears
25d ago
SEC filing
IRWD Reports $273M LINZESS Net Sales, $107M Total Revenue, $41M GAAP Net Income, +97% YoY Growth, sNDA Accepted, May 24 PDUFA, Apraglutide Phase 3 Initiation Q2
26d ago
Short volume
Short volume 78% of volume (4.9σ)
27d ago
Short volume
Short volume 62% of volume (3.4σ)
35d ago
Insider trade
Sale by Alexander J Denner
76d ago
SEC filing
IRWD Notifies Wells Fargo of Liquidity Compliance, Extends Revolving Credit Facility to 2028
83d ago
News
3 Stocks Trading Near $5 With Massive Earnings Upside
113d ago
Short volume
Short volume 60% of volume (3.8σ)
114d ago
News
Kadant to Acquire voestalpine BÖHLER Profil
124d ago
News
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus
148d ago
News
Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever
150d ago
Get push alerts for IRWD
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS